- Tearlab (TEAR -5.5%) slips on a negative article out of Streetsweeper today.
- The short seller calls TEAR "a bleeding firm with a long history of failure." adding that many doctors are no longer using its machine for diagnostic eye testing, citing inaccuracies in testing data and calling it an outright lemon.
Tearlab getting hit by a negative StreetSweeper report
From other sites
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs